Targets — browse / sort / filter (view)
Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target
- id
- UniProt accession (human). Links to uniprot.org.
- gene_symbol
- Gene symbol (e.g. ITGB3).
- protein_name
- Protein name (UniProt).
- tier
- Tier 1 = PDB-anchored; Tier 1.5 = AlphaFold-confident.
- has_structure
- 1 if the target protein has a reported experimental 3D structure (PDB). This is the CORE requirement the aptamer-Kd layer is built around — filter to 1 for the structure-backed set.
- evidence_priority
- DETERMINISTIC, reproducible prioritisation (0-1) computed at build time from real harvested columns: 0.35*experimental-structure(PDB=1 / AlphaFold-only=0.3) + 0.30*Open-Targets-top-disease-score + 0.20*PREDICTED-surface-accessibility(A_surface=1) + 0.15*EV-detection(EV-Map). A transparent ranking AID, not a validation; the surface/EV terms are PREDICTIONS/DETECTIONS, not measured EV-surface exposure. Recomputable exactly from this DB.
- has_activation_state_pdb_pair
- 1 if a curated ACTIVE/INACTIVE PDB pair exists (only 11 targets).
- in_cev_map
- Detected in the EV-Map plasma-EV dataset (Rai & Greening 2025, Nat Cell Biol, 10.1038/s41556-025-01795-7) = 3,422 apt-scout targets (broad detected proteome). The EV-Map CONSERVED EV proteome is 182 proteins (42 non-EV); apt-scout matches 104 of these conserved EV-hallmark proteins as targets by gene (the other 78 are not apt-scout targets). Use the ev_hallmark_targets query for that subset. IMPORTANT: EV-Map detection means the protein is EV CARGO (present in the vesicle) — it does NOT mean surface-exposed. Rai & Greening 2025 run a separate membrane-impermeant biotinylation assay giving a 151-protein SURFACEOME, and show the conserved SDCBP/syntenin is luminal (not surface-accessible). For genuine EV-surface accessibility use that 151-protein set, not EV-Map presence.
- has_known_aptamer
- 1 if PubMed '(gene) AND (aptamer OR SELEX)' returned any hit (KEYWORD co-mention, includes false positives — NOT a verified aptamer). For verified aptamers with Kd, see the Binding-affinities (v_kd) layer.
- opentargets_top_disease_score
- Open Targets association score (0-1).
- aptamer_count_pubmed
- Number of PubMed hits for (this protein) AND (aptamer OR SELEX). Keyword co-occurrence — verify each (many co-mention without a real aptamer).
- aptamer_pmids
- The actual PubMed IDs behind the aptamer evidence — click each to read the paper. This is the source of the 'has aptamer' claim.
- surface_class
- PREDICTED membrane topology (HPA-derived, not a measurement): A_surface = integral/ecto cell-surface (predicted EV-surface accessible); A2_pm_peripheral = plasma-membrane cytoplasmic-leaflet (SRC/LYN/RHOA, predicted not reachable); A_assoc = secreted/corona; B_cargo = luminal cargo; unknown = no HPA localization. Lipid asymmetry can partially flip (PS via scramblase); confirm by protease-protection / intact-EV surface labelling. See v_surface_targets.
428 rows where has_cryoEM = 1 and has_known_aptamer = 1 sorted by evidence_priority descending
This data as json, CSV (advanced)
surface_class 5
- B_cargo 202
- A_surface 120
- A_assoc 80
- A2_pm_peripheral 23
- unknown 3
tier 4
- Tier 1 324
- Tier 1.5 102
- Negative Control 1
- Positive Control 1
has_structure 1
- 1 428
has_known_aptamer 1
- 1 · 428 ✖
has_cryoEM 1
- 1 · 428 ✖
| id | gene_symbol | protein_name | tier | evidence_priority ▲ | has_structure | surface_class | pdb_count_total | alphafold_mean_pLDDT | has_cryoEM | has_activation_state_pdb_pair | activation_state_pdb_active | activation_state_pdb_inactive | has_known_aptamer | aptamer_count_pubmed | aptamer_pmids | in_cev_map | opentargets_top_disease_name | opentargets_top_disease_score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P21359 | NF1 | Neurofibromin | Tier 1.5 | 0.965 | 1 | A_surface | 26 | 87.19 | 1 | 0 | 1 | 2 | 32980430, 22617876 | 1 | neurofibromatosis type 1 | 0.8844735398780649 | ||
| P04839 | CYBB | NADPH oxidase 2 | Tier 1 | 0.959 | 1 | A_surface | 6 | 90.25 | 1 | 0 | 1 | 2 | 24635113 | 1 | chronic granulomatous disease | 0.8633132852459866 | ||
| P29965 | CD40LG | CD40 ligand | Tier 1 | 0.954 | 1 | A_surface | 8 | 82.62 | 1 | 0 | 1 | 6 | 37331977, 36203210, 26504624 | 1 | hyper-IgM syndrome type 1 | 0.8451678829647167 | ||
| P37173 | TGFBR2 | TGF-beta receptor type-2 | Tier 1 | 0.952 | 1 | A_surface | 22 | 81.0 | 1 | 0 | 1 | 8 | 32452828, 30595527, 29522674, 29375127, 26284552, 23999222, 22899759, 11856769 | 1 | Loeys-Dietz syndrome | 0.8390072008866913 | ||
| P19438 | TNFRSF1A | Tumor necrosis factor receptor superfamily member 1A | Tier 1 | 0.951 | 1 | A_surface | 13 | 71.38 | 1 | 0 | 1 | 1 | 35197258 | 1 | TNF receptor 1-associated periodic fever syndrome | 0.8352778213184682 | ||
| P06744 | GPI | Glucose-6-phosphate isomerase | Tier 1 | 0.949 | 1 | A_surface | 13 | 97.94 | 1 | 0 | 1 | 19 | 41911185, 41329468, 41232387, 35821507, 34953205, 32730952, 29501157, 27419372, 25919296, 25483705, 24334484, 23656757, 23578283, 23018995, 22116094, 20967861, 17574575, 27380815 | 1 | hemolytic anemia due to glucophosphate isomerase deficiency | 0.8306909118751346 | ||
| P36897 | TGFBR1 | TGF-beta receptor type-1 | Tier 1 | 0.948 | 1 | A_surface | 44 | 84.19 | 1 | 0 | 1 | 1 | 41089000 | 1 | Loeys-Dietz syndrome 1 | 0.8275292516338373 | ||
| P22607 | FGFR3 | Fibroblast growth factor receptor 3 | Tier 1 | 0.948 | 1 | A_surface | 13 | 74.19 | 1 | 0 | 1 | 6 | 38569854, 37704353, 34864168, 33952673, 31357131 | 1 | achondroplasia | 0.8270702096931246 | ||
| P04156 | PRNP | Major prion protein | Tier 1 | 0.947 | 1 | A_surface | 70 | 64.19 | 1 | 0 | 1 | 2 | 39556313, 34067472 | 1 | Gerstmann-Straussler-Scheinker syndrome | 0.8246149684620239 | ||
| P05106 | ITGB3 | Integrin beta-3 | Positive Control | 0.946 | 1 | A_surface | 123 | 87.0 | 1 | 1 | 8T2U | 8T2V | 1 | 2 | 22133781, 23544955 | 1 | Glanzmann thrombasthenia 1 | 0.8208115968652424 |
| P08069 | IGF1R | Insulin-like growth factor 1 receptor | Tier 1 | 0.945 | 1 | A_surface | 46 | 78.0 | 1 | 0 | 1 | 10 | 40997970, 39263947, 33410883, 30041514, 23373648, 16019422, 15231297 | 1 | growth delay due to insulin-like growth factor I resistance | 0.8166352227841136 | ||
| P16234 | PDGFRA | Platelet-derived growth factor receptor alpha | Tier 1.5 | 0.945 | 1 | A_surface | 14 | 72.69 | 1 | 0 | 1 | 4 | 33334063, 32127469, 28010895, 30594071 | 1 | gastrointestinal stromal tumor | 0.8167494524079806 | ||
| Q13563 | PKD2 | Polycystin-2 | Tier 1 | 0.943 | 1 | A_surface | 31 | 70.12 | 1 | 0 | 1 | 3 | 41315228, 36126144 | 1 | polycystic kidney disease 2 | 0.810960823768978 | ||
| P58335 | ANTXR2 | Anthrax toxin receptor 2 | Tier 1 | 0.941 | 1 | A_surface | 14 | 71.81 | 1 | 0 | 1 | 4 | 41503480, 41083485, 41020397, 40313273 | 1 | hyaline fibromatosis syndrome | 0.8028849863986661 | ||
| P61073 | CXCR4 | C-X-C chemokine receptor type 4 | Tier 1 | 0.94 | 1 | A_surface | 33 | 82.25 | 1 | 0 | 1 | 17 | 40671676, 40401615, 39865939, 39778270, 37052638, 35157940, 33739080, 31737891, 31267721, 31097627, 28670693, 26265085, 25329893, 22811524, 22376154, 12498773, 41543187 | 1 | WHIM syndrome | 0.8009225456235435 | ||
| P15529 | CD46 | Membrane cofactor protein | Tier 1.5 | 0.934 | 1 | A_surface | 7 | 82.12 | 1 | 0 | 1 | 9 | 35114109, 34248841, 31761039, 31077760, 27734375, 19915929, 17046833, 11084032 | 1 | atypical hemolytic-uremic syndrome with MCP/CD46 anomaly | 0.7798469882597787 | ||
| P13987 | CD59 | CD59 glycoprotein | Tier 1 | 0.932 | 1 | A_surface | 17 | 79.31 | 1 | 0 | 1 | 1 | 19915929 | 1 | primary CD59 deficiency | 0.7738276843579196 | ||
| P02511 | CRYAB | Alpha-crystallin B chain | Tier 1 | 0.925 | 1 | A_surface | 21 | 75.75 | 1 | 0 | 1 | 2 | 28720498, 23530262 | 1 | myofibrillar myopathy 2 | 0.7505030087389963 | ||
| Q14432 | PDE3A | cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A | Tier 1 | 0.924 | 1 | A_surface | 9 | 60.25 | 1 | 0 | 1 | 1 | 34456709 | 1 | Brachydactyly - arterial hypertension | 0.7468849549430213 | ||
| P25445 | FAS | Tumor necrosis factor receptor superfamily member 6 | Tier 1.5 | 0.921 | 1 | A_surface | 7 | 77.88 | 1 | 0 | 1 | 17 | 40784034, 39897575, 37458448, 36908619, 35402075, 32270033, 31436946, 30594071, 30417194, 30339905, 26318819, 23980164, 23511245, 18997060, 18956014, 16729304, 16581027 | 1 | autoimmune lymphoproliferative syndrome type 1 | 0.7377210386590284 | ||
| P07204 | THBD | Thrombomodulin | Tier 1 | 0.92 | 1 | A_surface | 13 | 78.62 | 1 | 0 | 1 | 5 | 41988704, 34708097, 28549218, 21526769, 7622501 | 1 | thrombomodulin-related bleeding disorder | 0.7323266135403641 | ||
| Q9H244 | P2RY12 | P2Y purinoceptor 12 | Tier 1 | 0.919 | 1 | A_surface | 5 | 84.44 | 1 | 0 | 1 | 2 | 32679592, 19509485 | 1 | platelet-type bleeding disorder 8 | 0.7304079345653686 | ||
| P08575 | PTPRC | Receptor-type tyrosine-protein phosphatase C | Tier 1 | 0.916 | 1 | A_surface | 6 | 76.06 | 1 | 0 | 1 | 1 | 25251012 | 1 | immunodeficiency 104 | 0.7200430416648742 | ||
| Q9UNQ0 | ABCG2 | Broad substrate specificity ATP-binding cassette transporter ABCG2 | Tier 1 | 0.915 | 1 | A_surface | 29 | 85.25 | 1 | 0 | 1 | 8 | 40873307, 36807620, 35544739, 33833512, 31180052, 31085078, 26176230, 24319544 | 1 | gout | 0.7158028003520317 | ||
| P13612 | ITGA4 | Integrin alpha-4 | Tier 1 | 0.914 | 1 | A_surface | 7 | 84.44 | 1 | 0 | 1 | 3 | 30065768, 28670693, 26504766 | 1 | Crohn's disease | 0.7134551179424343 | ||
| O75581 | LRP6 | Low-density lipoprotein receptor-related protein 6 | Tier 1 | 0.911 | 1 | A_surface | 27 | 79.19 | 1 | 0 | 1 | 5 | 42031715, 37175248, 18673242 | 1 | tooth agenesis, selective, 7 | 0.7022725510765017 | ||
| P40189 | IL6ST | Interleukin-6 receptor subunit beta | Tier 1 | 0.911 | 1 | A_surface | 20 | 74.62 | 1 | 0 | 1 | 2 | 39571081, 22258147 | 1 | Autosomal recessive hyper-IgE syndrome | 0.7027634038262931 | ||
| Q15303 | ERBB4 | Receptor tyrosine-protein kinase erbB-4 | Tier 1 | 0.903 | 1 | A_surface | 14 | 73.12 | 1 | 0 | 1 | 3 | 32592467, 30697465, 23990977 | 1 | non-small cell lung carcinoma | 0.6754899662390331 | ||
| O15455 | TLR3 | Toll-like receptor 3 | Tier 1 | 0.899 | 1 | A_surface | 20 | 90.62 | 1 | 0 | 1 | 7 | 26018150, 25528762, 17150912, 17150911 | 1 | Herpetic encephalitis | 0.6617401048830444 | ||
| P07550 | ADRB2 | Beta-2 adrenergic receptor | Tier 1 | 0.89 | 1 | A_surface | 100 | 79.12 | 1 | 0 | 1 | 2 | 41637639, 32376022 | 1 | asthma | 0.634300392456126 | ||
| P11836 | MS4A1 | B-lymphocyte antigen CD20 | Tier 1 | 0.888 | 1 | A_surface | 10 | 70.5 | 1 | 0 | 1 | 2 | 39865939, 29561802 | 1 | chronic lymphocytic leukemia | 0.6275806230802832 | ||
| P02786 | TFRC | Transferrin receptor protein 1 | Tier 1.5 | 0.887 | 1 | A_surface | 22 | 86.69 | 1 | 0 | 1 | 3 | 39831311, 29046922, 32527800 | 1 | TFRC-related combined immunodeficiency | 0.623449899069336 | ||
| P01133 | EGF | Pro-epidermal growth factor | Tier 1 | 0.886 | 1 | A_surface | 13 | 70.31 | 1 | 0 | 1 | 34 | 41906877, 41873087, 41693575, 39408993, 38904251, 38837175, 37423441, 35213974, 34893239, 32511241, 32200913, 31990606, 31004648, 30809312, 36132464, 28842588, 28029038, 27301192, 26504624, 25450403, 25261371, 24777583, 23531534, 23104156, 21999227, 21687663, 21576228, 19420593, 19063705, 20641927, 15037656, 13680379, 12842895, 12173045 | 1 | cancer | 0.6205045573389423 | ||
| P60033 | CD81 | CD81 antigen | Tier 1 | 0.885 | 1 | A_surface | 16 | 87.38 | 1 | 0 | 1 | 5 | 34505435, 32730952, 28959386, 23877701, 19997645 | 1 | immunodeficiency, common variable, 6 | 0.6168240011812034 | ||
| P00451 | F8 | Coagulation factor VIII | Tier 1 | 0.873 | 1 | A_assoc | 25 | 60.75 | 1 | 0 | 1 | 13 | 40727755, 40266188, 28791655, 21144556, 41587892, 40009491, 38992298, 38752747, 31493779, 29609491, 28979328, 21389323, 20589313 | 1 | hemophilia A | 0.9108044347811838 | ||
| P51679 | CCR4 | C-C chemokine receptor type 4 | Tier 1 | 0.862 | 1 | A_surface | 7 | 80.75 | 1 | 0 | 1 | 3 | 41518674, 39071952, 29103909 | 1 | mycosis fungoides | 0.5404546856597274 | ||
| P05362 | ICAM1 | Intercellular adhesion molecule 1 | Tier 1 | 0.859 | 1 | A_surface | 14 | 88.44 | 1 | 0 | 1 | 43 | 41699153, 40650261, 40539828, 40329889, 39154820, 37052638, 36508319, 35312740, 35212764, 34038704, 32884147, 32784904, 30697465, 30617526, 28631505, 27132231, 25582325, 25368913, 21147843, 20665479, 12714656, 11320245, 10097084, 9740353, 9200462, 8932275 | 1 | neurodegenerative disease | 0.5292405353144124 | ||
| Q9NNX6 | CD209 | CD209 antigen | Tier 1 | 0.858 | 1 | A_surface | 14 | 71.44 | 1 | 0 | 1 | 1 | 37017594 | 1 | dengue disease | 0.5252368050139995 | ||
| O95858 | TSPAN15 | Tetraspanin-15 | Tier 1 | 0.855 | 1 | A_surface | 3 | 87.56 | 1 | 0 | 1 | 1 | 37047289 | 1 | venous thromboembolism | 0.5182425801223098 | ||
| P02452 | COL1A1 | Collagen alpha-1(I) chain | Tier 1 | 0.854 | 1 | A_assoc | 14 | 52.72 | 1 | 0 | 1 | 3 | 40407197, 35905589, 15132764 | 1 | osteogenesis imperfecta type 2 | 0.8471150130101988 | ||
| P11717 | IGF2R | Cation-independent mannose-6-phosphate receptor | Tier 1 | 0.853 | 1 | A_surface | 24 | 73.12 | 1 | 0 | 1 | 5 | 40554308, 39225423, 38059276, 36126144, 32040773 | 1 | coronary artery disease | 0.511249370339317 | ||
| P15144 | ANPEP | Aminopeptidase N | Tier 1 | 0.851 | 1 | A_surface | 15 | 93.06 | 1 | 0 | 1 | 1 | 33554306 | 1 | cholelithiasis | 0.5030146927270738 | ||
| P45379 | TNNT2 | Troponin T, cardiac muscle | Tier 1 | 0.85 | 1 | A_assoc | 25 | 78.31 | 1 | 0 | 1 | 4 | 41020397, 40313273, 31782481, 30979922 | 1 | hypertrophic cardiomyopathy | 0.8329996050513441 | ||
| P00747 | PLG | Plasminogen | Tier 1 | 0.847 | 1 | A_assoc | 49 | 82.81 | 1 | 0 | 1 | 51 | 24641476, 41699153, 41371773, 41335958, 38963794, 37533140, 37360033, 37149949, 36882463, 36859809, 36358641, 36203210, 36156780, 35715131, 35563278, 35197258, 33918821, 33859620, 33674695, 32199927, 31870256, 30197987, 30015643, 28051346, 27813404, 27755560, 27679852, 26926041, 26876003, 26163061, 25855589, 25793507, 25620243, 25582325, 24922319, 24682699, 24138169, 24012635, 23038812, 22103403, 21147843, 21142878, 20962041, 20594164, 20387790, 20050927, 19485299, 19284310, 18713263, 15560078, 15303967 | 1 | hypoplasminogenemia | 0.8240321266100769 | ||
| P07225 | PROS1 | Vitamin K-dependent protein S | Tier 1.5 | 0.847 | 1 | A_assoc | 3 | 82.94 | 1 | 0 | 1 | 2 | 36859809, 33674695 | 1 | thrombophilia due to protein S deficiency, autosomal dominant | 0.8240418292042652 | ||
| Q03405 | PLAUR | Urokinase plasminogen activator surface receptor | Tier 1 | 0.845 | 1 | A_surface | 13 | 81.44 | 1 | 0 | 1 | 2 | 37533140 | 1 | Abdominal Aortic Aneurysm | 0.4819526979346149 | ||
| P02649 | APOE | Apolipoprotein E | Tier 1 | 0.845 | 1 | A_assoc | 29 | 75.5 | 1 | 0 | 1 | 41 | 41437270, 41316897, 41276911, 40501769, 38895620, 38559166, 38397086, 38377941, 38256230, 36980195, 36579647, 35966595, 35869074, 35415203, 35359181, 34814699, 34757788, 34016094, 31878307, 31461490, 31385390, 29258991, 24589243, 22110600, 41505229, 40429697, 39939919, 36048760, 32831200, 30613278, 29214237, 24121966 | 1 | coronary artery disease | 0.81626595063263 | ||
| Q07108 | CD69 | Early activation antigen CD69 | Tier 1 | 0.844 | 1 | A_surface | 6 | 82.12 | 1 | 0 | 1 | 5 | 40448637, 39048513, 37110712, 32401486, 16331266 | 1 | hypothyroidism | 0.48068618377072814 | ||
| Q92633 | LPAR1 | Lysophosphatidic acid receptor 1 | Tier 1.5 | 0.843 | 1 | A_surface | 16 | 83.62 | 1 | 0 | 1 | 1 | 32065590 | 1 | Epiretinal membrane | 0.4757255248053499 | ||
| P08174 | CD55 | Complement decay-accelerating factor | Tier 1 | 0.84 | 1 | A_surface | 33 | 78.25 | 1 | 0 | 1 | 3 | 33398182, 19915929, 37566081 | 1 | Protein-losing enteropathy | 0.46728275901717004 |
Advanced export
JSON shape: default, array, newline-delimited
CREATE VIEW v_targets AS
SELECT f.id, n.gene_symbol, n.protein_name, tg.tier,
-- evidence_priority: DETERMINISTIC, reproducible from real DB columns (no LLM).
-- Transparent weights over harvested evidence: structure 0.35, disease importance
-- 0.30 (Open Targets top-disease score), PREDICTED surface accessibility 0.20,
-- EV detection 0.15. A heuristic ranking aid, not a validation; surface/EV terms
-- are predictions/detections, NOT measured EV-surface exposure.
ROUND(
0.35*(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1.0
WHEN CAST(COALESCE(NULLIF(f.alphafold_mean_pLDDT,''),'0') AS REAL)>0 THEN 0.3 ELSE 0.0 END)
+ 0.30*MIN(CAST(COALESCE(NULLIF(f.opentargets_top_disease_score,''),'0') AS REAL), 1.0)
+ 0.20*(CASE sc.surface_class WHEN 'A_surface' THEN 1.0 WHEN 'A_assoc' THEN 0.5 WHEN 'A2_pm_peripheral' THEN 0.2 ELSE 0.0 END)
+ 0.15*(CASE WHEN CAST(COALESCE(f.in_cev_map,0) AS INTEGER)=1 THEN 1.0 ELSE 0.0 END)
, 3) AS evidence_priority,
(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1 ELSE 0 END) AS has_structure,
sc.surface_class,
f.pdb_count_total, f.alphafold_mean_pLDDT, f.has_cryoEM,
f.has_activation_state_pdb_pair, f.activation_state_pdb_active, f.activation_state_pdb_inactive,
f.has_known_aptamer, f.aptamer_count_pubmed, ap.aptamer_pmids,
f.in_cev_map, f.opentargets_top_disease_name, f.opentargets_top_disease_score
FROM v_target_full f
LEFT JOIN target_names n ON n.target_id=f.id
LEFT JOIN targets tg ON tg.id=f.id
LEFT JOIN target_aptamer_pmids ap ON ap.target_id=f.id
LEFT JOIN membrane_surface_class sc ON sc.target_id=f.id;